Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-23

FDA Approved: AZSTARYS — Supplemental Application (Corium, LLC.)

View source ↗

Summary

The FDA approved a supplemental application for AZSTARYS (serdexmethylphenidate and dexmethylphenidate) by Corium, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azstarys (serdexmethylphenidate/dexmethylphenidate)

Snippet

SUPPL AP for AZSTARYS (SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE)